Investment Summary

General Atlantic Invests In KGbio

On September 23, 2021, growth capital firm General Atlantic invested in life science company KGbio

Investment Highlights
  • This is General Atlantic’s 14th transaction in the Life Science sector.
  • This is General Atlantic’s 2nd transaction in Indonesia.

Investment Summary

Date 2021-09-23
Target KGbio
Sector Life Science
Investor(s) General Atlantic
Deal Type Growth Capital

Target

KGbio

Jakarta, Indonesia
KGbio is a clinical-stage biotechnology company focused on bringing biologics medical innovation to markets outside the US/Canada, Western Europe and China. KGbio was founded in 2017 and is based in Jakarta, Indonesia.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

General Atlantic

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1980
PE ASSETS 105.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

General Atlantic is a large private equity firm that invests globally in growth-oriented public and private companies. Broad areas of interest include financial services, media and consumer, healthcare, enterprise solutions, communications and electronics, and energy. General Atlantic looks to invest $40 to $400 million in transactions that support growth, expansions, buy-outs, consolidations and build-ups. General Atlantic seeks to make 8 to 12 investments per year with an investment horizon of five to ten years. The Firm's geographic coverage spans North America; Europe; Asia/Pacific; and India. General Atlantic was formed in 1980 and is based in New York, New York.


DEAL STATS #
Overall 298 of 364
Sector: Life Science M&A 14 of 20
Type: Growth Capital M&A Deals 123 of 140
Country: Indonesia M&A 2 of 3
Year: 2021 M&A 34 of 46
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-13 EngageSmart

Braintree, Massachusetts, United States

EngageSmart delivers SaaS platforms that drive customer engagement, operational efficiency, and convenient billing and digital payments across multiple vertical end markets. EngageSmart was founded in 2018 and is based in Braintree, Massachusetts.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-28 Stellar Health

New York, New York, United States

Stellar Health is a healthcare technology company. Stellar Health empowers providers to deliver value-based care through their cloud-native point-of-care platform. By integrating patient data, tracking provider workflows, and pushing meaningful, actionable insights directly to providers and practice staff, the platform helps primary care providers achieve value-based care outcomes for their patients. Stellar Health was founded in 2018 and is based in New York, New York.

Buy -